HLUN Stock Overview

HLUN fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Latest financial reports are more than a year old

High level of non-cash earnings

Does not have a meaningful market cap ($117)

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

HEALTHeUNIVERSE, Inc. Competitors

DermTech

OTCPK:DMTK.Q

US$35.0

eFFECTOR Therapeutics

OTCPK:EFTR

US$940.0

Genocea Biosciences

OTCPK:GNCA.Q

US$5.9k

Juva Life

OTCPK:JUVA.F

US$164.0

Price History & Performance

Summary of share price highs, lows and changes for HEALTHeUNIVERSE
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.000016
52 Week Low	US$0.000001
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	0%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	HLUN	US Biotechs	US Market
7D	0%	0.2%	-0.2%
1Y	n/a	-4.7%	25.8%

Return vs Industry: Insufficient data to determine how HLUN performed against the US Biotechs industry.

Return vs Market: Insufficient data to determine how HLUN performed against the US Market.

Price Volatility

Is HLUN's price volatile compared to industry and market?
HLUN volatility
HLUN Average Weekly Movement	n/a
Biotechs Industry Average Movement	11.0%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.6%
10% least volatile stocks in US Market	3.1%

Stable Share Price: HLUN's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine HLUN's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2001	n/a	Vipul Dev	n/a

Healtheuniverse, Inc., a biotechnology development company, engages in the research, development, and commercialization of biopharmaceutical, biomedical, nutraceutical, and cosmeceutical products. The company develops stem cell and regenerative medicine therapies utilizing non-embryonic adult stem cells for use in plastic and reconstructive surgery, orthopedic surgery, vascular surgery, cardiac surgery, and wound care. It also provides consulting services to various businesses in the areas of marketing, business organization, and raising capital for business ventures.

HEALTHeUNIVERSE, Inc. Fundamentals Summary

How do HEALTHeUNIVERSE's earnings and revenue compare to its market cap?
HLUN fundamental statistics
Market cap	US$117.00
Earnings (TTM)	US$42.80k
Revenue (TTM)	US$481.79k

0.0x

P/E Ratio

0.0x

P/S Ratio

Is HLUN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HLUN income statement (TTM)
Revenue	US$481.79k
Cost of Revenue	US$18.63k
Gross Profit	US$463.15k
Other Expenses	US$420.35k
Earnings	US$42.80k

Last Reported Earnings

Sep 30, 2006

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did HLUN perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/06 03:00
End of Day Share Price	2024/11/13 00:00
Earnings	2006/09/30
Annual Earnings	2005/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

HEALTHeUNIVERSE, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution